RACHEL DUKE: Open Payments
NPI 1699139998 · TAMPA, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$4,038 in 34 payments from 10 companies in 2025. Trend: 2023 $366 · 2024 $1,155 · 2025 $4,038
Food & beverage: $1,880Consulting: $1,080Travel & lodging: $1,079
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 13 | $1,879 |
| TG Therapeutics, Inc. | 7 | $1,429 |
| Biogen, Inc. | 4 | $314 |
| ABBVIE INC. | 2 | $131 |
| EMD Serono, Inc. | 3 | $94 |
| Celgene Corporation | 1 | $72 |
| GENZYME CORPORATION | 1 | $41 |
| Amgen Inc. | 1 | $34 |
| Genentech, Inc. | 1 | $24 |
| Galderma Laboratories, L.P. | 1 | $21 |
Products named: BRIUMVI, KESIMPTA, BOTOX, VUMERITY, ZEPOSIA, UPLIZNA, TYSABRI, Ocrevus.
Industry payments across FL — which companies pay providers there.
